|
|
Volumn 80, Issue 1, 2005, Pages 75-80
|
|
Improving access to kidney transplantation without decreasing graft survival: Long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients
a
|
|
Author keywords
10 year; A2; B; Kidney; Survival
|
|
Indexed keywords
AZATHIOPRINE;
BLOOD GROUP A ANTIBODY;
CYCLOSPORIN;
IMMUNOGLOBULIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
ANTIBODY PRODUCTION;
ANTIBODY TITER;
ARTICLE;
BLOOD GROUP A;
BLOOD GROUP AB;
BLOOD GROUP ABO SYSTEM;
BLOOD GROUP B;
CAUSE OF DEATH;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
GRAFT SURVIVAL;
HOSPITAL ADMISSION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DONOR;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ABO BLOOD-GROUP SYSTEM;
CADAVER;
FEMALE;
GRAFT SURVIVAL;
HUMANS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MINORITY GROUPS;
REOPERATION;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TISSUE DONORS;
TREATMENT OUTCOME;
|
|
EID: 22144456404
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/01.TP.0000164288.82238.52 Document Type: Article |
|
Times cited : (31)
|
|
References (8)
|
